Bristol-Myers Squibb Company and Karuna Therapeutics have signed an agreement for a merger, with each share of Karuna common stock being converted into $330.00 in cash.
AI Assistant
BRISTOL MYERS SQUIBB CO
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.